EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Elevated plasma klotho levels attenuate Alzheimer's disease pathologies and cognitive decline in APOE ε4 carriers

Jie Yang, Jinghua Wang, Wenhui Chai, Laihong Zhang, Anqi Li, Guoyu Lan, Mingxing Jiang, Xiang Fan, Hongjie Yang, Jun Li, Yalin Zhu, Yue Cai und 11 weitere

Alzheimer's & Dementia · 2026-04 · 22 (4)

DOI: 10.1002/alz.71397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 17.04.2026. Verfasst von Jie Yang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoprotein E4, Cognitive Dysfunction, Glucuronidase. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shenzhen Science and Technology Program, National Natural Science Foundation of China, STI2030-Major Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Klotho is a longevity‐associated protein with established neuroprotective properties. However, it is unclear how plasma klotho levels relate to Alzheimer's disease (AD) pathologies and cognitive performance. METHODS In this study, we examined the associations between plasma klotho levels and plasma biomarkers, as well as amyloid beta (Aβ) positron emission tomography (PET), tau PET, neurodegeneration, and cognition, in 354 older adults. Stratified association, interaction, and mediation analyses were conducted to elucidate apolipoprotein E ( APOE ) ε4–dependent relationships and potential underlying pathways. RESULTS Higher plasma klotho levels were associated with lower AD‐related biomarkers and cognitive decline in APOE ε4 carriers. Plasma klotho and APOE ε4 exhibited significant or marginal interactions with less abnormal changes in plasma phosphorylated tau217, glial fibrillary acidic protein, neurofilament light chain, Aβ PET, and cognition. These AD‐related biomarkers mediated the protective effect of plasma klotho on cognitive function in APOE ε4 carriers. DISCUSSION This study suggests that plasma klotho is an APOE ε4–dependent protective factor, which may attenuate AD‐related pathology and improve cognitive performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseApolipoprotein E4Cognitive DysfunctionGlucuronidaseHumansKlotho ProteinsFemaleMalePositron-Emission TomographyAmyloid beta-PeptidesAgedBiomarkerstau ProteinsHeterozygoteAged, 80 and overBrain

Stichwörter der Autor:innen

Alzheimer's diseaseapolipoprotein E ε4 carriercognitive declineplasma klotho

Substanzen

Klotho ProteinsApolipoprotein E4Amyloid beta-PeptidesGlucuronidaseBiomarkerstau ProteinsKL protein, human

Autor:innen und Institutionen

  • Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen, China.
  • Department of Neurology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
  • Changji Hui Autonomous Prefecture People's Hospital, Changji, China.
  • School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
  • Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong Special Administrative Region, China.

ORCID-Profile: Mengjie Dong, Ying Han, Tengfei Guo

Förderung

  • Shenzhen Science and Technology Program
  • National Natural Science Foundation of China
  • STI2030-Major Projects
  • Guangdong Basic and Applied Basic Science Foundation
  • Shenzhen Bay Laboratory
  • Lingang Laboratory
  • the Sino-German Cooperation
  • Initiative Funding of Hainan University

Zitieren

APA

Yang, J., Wang, J., Chai, W., Zhang, L., Li, A., Lan, G., Jiang, M., Fan, X., Yang, H., Li, J., Zhu, Y., Cai, Y., Sun, P., He, Z., Zhou, X., Liu, Z., Wang, Q., Chen, X., Cheng, G., …, & Guo, T. (2026). Elevated plasma klotho levels attenuate Alzheimer's disease pathologies and cognitive decline in APOE ε4 carriers. Alzheimer's & Dementia, 22(4). https://doi.org/10.1002/alz.71397

Vancouver

Yang J, Wang J, Chai W, Zhang L, Li A, Lan G, et al. Elevated plasma klotho levels attenuate Alzheimer's disease pathologies and cognitive decline in APOE ε4 carriers. Alzheimer's & Dementia. 2026;22(4). doi:10.1002/alz.71397

BibTeX
@article{Yang2026,
  author = {Yang, Jie and Wang, Jinghua and Chai, Wenhui and Zhang, Laihong and Li, Anqi and Lan, Guoyu and Jiang, Mingxing and Fan, Xiang and Yang, Hongjie and Li, Jun and Zhu, Yalin and Cai, Yue and Sun, Pan and He, Zhengbo and Zhou, Xin and Liu, Zhen and Wang, Qingyong and Chen, Xuhui and Cheng, Guanxun and Wang, Lu and Dong, Mengjie and Han, Ying and Guo, Tengfei},
  title = {Elevated plasma klotho levels attenuate Alzheimer's disease pathologies and cognitive decline in APOE ε4 carriers},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {4},
  doi = {10.1002/alz.71397}
}
Kostenlos starten →